Omeros Corp.
(NASDAQ : OMER)

( )
OMER After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.66%196.941.3%$565.97m
GILDGilead Sciences, Inc.
0.70%66.420.9%$368.71m
BIIBBiogen Inc.
1.35%238.791.3%$340.32m
ILMNIllumina, Inc.
1.43%309.573.5%$338.07m
ALXNAlexion Pharmaceuticals, Inc.
0.62%106.322.0%$332.28m
CELGCelgene Corporation
0.42%99.371.3%$309.99m
REGNRegeneron Pharmaceuticals, Inc.
3.40%295.872.6%$188.33m
VRTXVertex Pharmaceuticals Incorporated
1.12%178.121.9%$186.01m
AAgilent Technologies, Inc.
-0.18%77.931.6%$185.14m
EXASExact Sciences Corporation
0.55%103.9724.1%$152.91m
SRPTSarepta Therapeutics, Inc.
-3.34%82.5114.6%$139.60m
ACADACADIA Pharmaceuticals Inc.
-2.26%40.7413.9%$129.03m
INCYIncyte Corporation
3.96%81.212.5%$93.98m
ALDRAlder Biopharmaceuticals, Inc.
-0.11%18.6410.2%$81.98m
BMRNBioMarin Pharmaceutical Inc.
-1.38%74.954.3%$76.08m

Company Profile

Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.